TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,133,610
|
2,351,227
|
1,007,840 |
| Earnings before taxes |
65,279
|
53,544
|
30,679 |
| Total assets |
532,463
|
1,166,287
|
487,496 |
| Current assets |
509,040
|
561,967
|
487,194 |
| Current liabilities |
322,299
|
325,945
|
286,057 |
| Equity capital |
207,813
|
731,991
|
197,333 |
| - share capital |
5,955
|
5,986
|
5,501 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.0%
|
62.8%
|
40.5% |
| Turnover per employee |
7,557
|
15,675
|
6,719 |
| Profit as a percentage of turnover |
5.8%
|
2.3%
|
3.0% |
| Return on assets (ROA) | |||
| Current ratio |
157.9%
|
172.4%
|
170.3% |
| Return on equity (ROE) |
31.4%
|
7.3%
|
15.5% |
| Change turnover |
-1,205,571
|
1,254,556
|
42,609 |
| Change turnover % |
-52%
|
114%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.